HEMEX contributes as a smart money investor with strong clinical development expertise to the healthcare of tomorrow. With skin in the game, we act as a long-term partner that can assist in data collection.

Our investments are entirely focused on regulated healthcare products and technologies, which meet the United Nations’ sustainable development goals (SDGs 3,4 and 3,7 and 3d). Along with our follow-up investments in high performing portfolio companies, we aim to pursue 2-3 new projects per year, preferably from series A onwards.